← ALTERITY THERAPEUTICS LTD
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income | — | — | — | — | — | — | ($12.8m) |
($13.8m)
-7.47%
|
($19.1m)
-38.51%
|
($12.1m)
+36.48%
|
($12.1m)
0.00%
|
|
| Profit or Loss | — | — | ($8.3m) | ($12.3m) | ($13.5m) | ($15.3m) | ($12.8m) | ($13.8m) | ($19.1m) | ($12.1m) | — | |
| Depreciation | — | — | — | — | — | — | $54k | $102k | $148k | $140k | $140k | |
| Adjustments For Share-Based Payments | — | — | — | — | — | — | — | — | $882k | $980k | — | |
| Asset Impairment Charge | — | — | — | — | — | — | $0 | $10k | $0 | $0 | $0 | |
| Change In Working Capital | — | — | — | — | — | — | $1.8m | ($6.4m) | $5.7m | ($614k) | ($614k) | |
| Change In Receivables | — | — | — | — | — | — | ($448k) | ($3.9m) | $4.6m | $104k | $104k | |
| Change In Other Current Assets | — | — | — | — | — | — | ($516k) | ($968k) | $253k | $1.1m | $1.1m | |
| Change In Other Current Liabilities | — | — | — | — | — | — | $0 | $0 | ($12k) | ($100k) | ($100k) | |
| Payments for purchase of plant and equipment | — | ($28k) | ($62k) | ($7k) | ($17k) | ($10k) | ($89k) | ($7k) | ($6k) | — | — | |
| Net cash flows used in investing activities | — | ($28k) | ($18k) | ($7k) | ($17k) | ($10k) | ($89k) | ($36k) | ($6k) | ($7.5m) | — | |
| Long Term Debt Payments | — | — | — | — | — | — | ($35k) | ($60k) | ($10k) | ($127k) | ($127k) | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | ($35k) | ($60k) | ($10k) | ($127k) | ($127k) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | ($35k) | ($60k) | ($10k) | ($127k) | ($127k) | |
| Repayment Of Debt | — | — | — | — | — | — | ($35k) | ($60k) | ($10k) | ($127k) | ($127k) | |
| Common Stock Issuance | — | — | — | — | — | — | $17.2m | $317k | $10.1m | $42.6m | $47.6m | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $17.2m | $317k | $10.1m | $42.6m | $47.6m | |
| Net Other Financing Charges | — | — | — | — | — | — | ($837k) | ($132k) | ($918k) | ($2.8m) | ($3.0m) | |
| Net cash flows generated from financing activities | — | ($160k) |
($108k)
+32.52%
|
$12.7m
+11915.14%
|
$4.0m
-68.70%
|
$36.7m
+821.32%
|
$16.3m
-55.56%
|
$124k
-99.24%
|
$9.2m
+7312.17%
|
$39.7m
+330.43%
|
— | |
| Net (decrease)/increase in cash and cash equivalents | — | ($6.1m) | ($6.4m) | ($1.2m) | ($5.5m) | $19.3m | $3.9m | ($19.9m) | ($3.4m) | $20.7m | — | |
| Cash and cash equivalents at beginning of period | $28.6m | $21.9m | $15.2m | $14.4m | $9.2m | $28.1m | $34.8m | $15.8m | $12.6m | $33.2m | — | |
| Beginning Cash Position | — | — | — | — | — | — | $28.1m | $34.8m | $15.8m | $12.6m | $18.0m | |
| Exchange rate adjustments on cash and cash equivalents held in foreign currencies | — | $656k | $278k | $404k | $263k | ($427k) | $2.8m | $915k | $260k | ($198k) | — | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | $2.8m | $915k | $260k | ($198k) | ($138k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Additional Financial Items | ||||||||||||
| Adjustments For Current Tax Of Prior Period | — | — | $0 | $0 | — | — | $20k | $71k | ($12k) | ($9k) | — | |
| General And Administrative Expense | — | — | $4.3m | $4.3m | $3.4m | $6.9m | $5.5m | $5.1m | $4.8m | $5.5m | — | |
| Interest Paid Classified As Operating Activities | — | — | — | — | $4k | $1k | $2k | $5k | $7k | $0 | — | |
| Interest Received Classified As Operating Activities | — | $148k | $199k | $119k | $19k | $20k | $3k | $16k | $269k | $446k | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | — | — | — | — | — | $10k | $127k | — | |
| Payments to suppliers and employees | — | ($10.8m) | ($9.5m) | ($17.3m) | ($14.4m) | ($17.7m) | ($16.9m) | ($19.9m) | ($21.4m) | ($17.5m) | — | |
| R&D tax refund | — | $4.8m | $3.0m | $3.3m | $4.8m | — | $4.1m | — | $8.6m | $5.6m | — | |
| Income tax paid | — | — | — | — | — | — | ($43k) | ($103k) | ($58k) | ($68k) | — | |
| Proceeds from issue of ordinary shares and other equity securities | — | — | — | — | — | — | $17.2m | $317k | $10.1m | $42.6m | — | |
| Payment of share issue costs | — | ($160k) | ($108k) | ($362k) | ($293k) | ($2.5m) | ($837k) | ($132k) | ($918k) | ($2.8m) | — | |
| Principal elements of lease payments | — | — | — | — | ($89k) | ($58k) | ($35k) | ($60k) | ($10k) | ($127k) | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $16.3m | $124k | $9.2m | $39.7m | $44.4m | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($89k) | ($36k) | ($6k) | ($7.5m) | ($7.5m) | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $3.9m | ($19.9m) | ($3.4m) | $20.7m | — | |
| Change In Other Working Capital | — | — | — | — | — | — | $123k | $79k | ($218k) | $345k | $345k | |
| Change In Payable | — | — | — | — | — | — | $2.6m | ($1.6m) | $1.1m | ($2.0m) | ($2.0m) | |
| Changes In Cash | — | — | — | — | — | — | $3.9m | ($19.9m) | ($3.4m) | $20.7m | $19.2m | |
| Classesof Cash Payments | — | — | — | — | — | — | ($16.9m) | ($20.0m) | ($21.5m) | ($17.5m) | ($23.2m) | |
| End Cash Position | — | — | — | — | — | — | $34.8m | $15.8m | $12.6m | $33.2m | $37.2m | |
| Financing Cash Flow | — | — | — | — | — | — | $16.3m |
$124k
-99.24%
|
$9.2m
+7312.17%
|
$39.7m
+330.43%
|
$44.4m
+11.95%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($12.4m) | ($20.0m) | ($12.6m) | ($11.5m) | ($17.7m) | |
| Interest Received Direct | — | — | — | — | — | — | $3k | $16k | $269k | $446k | $1.5m | |
| Investing Cash Flow | — | — | — | — | — | — | ($89k) | ($36k) | ($6k) | ($7.5m) | ($7.5m) | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | — | ($2.8m) | ($918k) | ($261k) | ($259k) | ($259k) | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | — | $0 | $0 | ($7.5m) | ($7.5m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($89k) | ($7k) | ($6k) | $0 | $0 | |
| Operating Gains Losses | — | — | — | — | — | — | ($2.8m) | ($918k) | ($261k) | ($259k) | ($259k) | |
| Other Non Cash Items | — | — | — | — | — | — | $61 | — | — | $450k | — | |
| Paymentsto Suppliersfor Goodsand Services | — | — | — | — | — | — | ($16.9m) | ($19.9m) | ($21.4m) | ($17.5m) | ($17.5m) | |
| Purchase Of Investment | — | — | — | — | — | — | — | $0 | $0 | ($7.5m) | ($7.5m) | |
| Purchase Of PPE | — | — | $62k | $7k | $17k | $10k | ($89k) | ($7k) | ($6k) | $0 | ($6k) | |
| Receiptsfrom Government Grants | — | — | — | — | — | — | $454k | $0 | — | — | $5.6m | |
| Stock Based Compensation | — | — | — | — | — | — | $1.5m | $967k | $882k | $980k | $980k |